11
TITLE: Chemical screening for novel therapeutic target identification in Machado-Joseph disease
AUTHORS: Vilasboas-Campos, D; Lopes, J; Ferreira-Lomba, B; J.D da Silva; M.D da Costa; Maciel, P; Teixeira-Castro, A;
PUBLISHED: 2022, SOURCE: Neuroscience Applied, VOLUME: 1
INDEXED IN: CrossRef
IN MY: ORCID
12
TITLE: Befiradol treatment ameliorated the motor dysfunction of Spinocerebellar Ataxia Type 3 mouse model
AUTHORS: Ferreira-Lomba, B; Guerreiro, S; Cunha-Garcia, D; Pereira-Sousa, J; Duarte-Silva, S; Teixeira-Castro, A; M.S Kleven; Vilasboas-Campos, D; Vidinha-Mira, A; Newman-Tancredi, A; Maciel, P;
PUBLISHED: 2022, SOURCE: Neuroscience Applied, VOLUME: 1
INDEXED IN: CrossRef
IN MY: ORCID
13
TITLE: Neurotherapeutic effect of Hyptis spp. leaf extracts in Caenorhabditis elegans models of tauopathy and polyglutamine disease: Role of the glutathione redox cycle  Full Text
AUTHORS: Vilasboas Campos, D; Costa, MD; Teixeira Castro, A; Rios, R; Silva, FG; Bessa, C; Dias, ACP; Maciel, P;
PUBLISHED: 2021, SOURCE: FREE RADICAL BIOLOGY AND MEDICINE, VOLUME: 162
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
14
TITLE: Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease  Full Text
AUTHORS: Pereira Sousa, J; Ferreira Lomba, B; Bellver Sanchis, A; Vilasboas Campos, D; Fernandes, JH; Costa, MD; Varney, MA; Newman Tancredi, A; Maciel, P; Teixeira Castro, A;
PUBLISHED: 2021, SOURCE: NEUROBIOLOGY OF DISEASE, VOLUME: 152
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
15
TITLE: Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease
AUTHORS: Marques, CR; Pereira Sousa, J; Teixeira, FG; Sousa, RA; Teixeira Castro, A; Salgado, AJ;
PUBLISHED: 2021, SOURCE: CYTOTHERAPY, VOLUME: 23, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
16
TITLE: Case Report: A Novel GNB1 Mutation Causes Global Developmental Delay With Intellectual Disability and Behavioral Disorders  Full Text
AUTHORS: Da Silva, JD; Costa, MD; Almeida, B; Lopes, F; Maciel, P; Teixeira Castro, A;
PUBLISHED: 2021, SOURCE: FRONTIERS IN NEUROLOGY, VOLUME: 12
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
17
TITLE: Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3
AUTHORS: Correia, JS; Neves Carvalho, A; Mendes Pinheiro, B; Pires, J; Teixeira, FG; Lima, R; Monteiro, S; Silva, NA; Soares Cunha, C; Serra, SC; Duarte Silva, S; Teixeira Castro, A; Salgado, AJ; Maciel, P;
PUBLISHED: 2021, SOURCE: BIOMEDICINES, VOLUME: 9, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
18
TITLE: Loss of egli-1, the Caenorhabditis elegans Orthologue of a Downstream Target of SMN, Leads to Abnormalities in Sensorimotor Integration  Full Text
AUTHORS: Da Silva, JD; Oliveira, S; Pereira Sousa, J; Teixeira Castro, A; Costa, MD; Maciel, P;
PUBLISHED: 2020, SOURCE: MOLECULAR NEUROBIOLOGY, VOLUME: 57, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
19
TITLE: Polyglutamine spinocerebellar ataxias: emerging therapeutic targets
AUTHORS: Neves Carvalho, A; Duarte Silva, S; Teixeira Castro, A; Maciel, P;
PUBLISHED: 2020, SOURCE: EXPERT OPINION ON THERAPEUTIC TARGETS, VOLUME: 24, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
20
TITLE: Data on the effects of Hyptis spp. and Lycium spp. plant extracts in C. elegans models of genetically determined neurodegenerative diseases
AUTHORS: Vilasboas Campos, D; Costa, MD; Teixeira Castro, A; Rios, R; Silva, FG; Aierken, A; Zhang, XY; Bessa, C; Dias, ACP; Maciel, P;
PUBLISHED: 2020, SOURCE: DATA IN BRIEF, VOLUME: 33
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
Page 2 of 4. Total results: 40.